If you listen to the drug pricing debate, you've probably heard a good deal about “middlemen” in the system, allegedly operating in the shadows and driving up prices.
The line is a cheap tactic, a ruse used by Big Pharma to evade culpability for the crisis of rising prescription drug prices and point the finger at others, namely pharmacy benefit managers (PBMs).
